Home › Companies › Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc. (NWBO) proxy voting records

How asset managers voted at Northwest Biotherapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• TickerNWBO
• CUSIP issuer number66737P
• SEC CIK1072379

Not to be confused with Northwest Bancshares, Inc. (company); Northwest Natural Holding Company (company).

Recent shareholder votes

• December 29, 2025 annual meeting (2025-2026 proxy season): 4 items in Northwest Biotherapeutics, Inc.'s official results (Form 8-K, filed January 2, 2026); lowest support 77% of votes cast (Advisory Vote on Executive Compensation. The common and…). Full results and how funds voted.
• June 29, 2024 annual meeting (2023-2024 proxy season): 6 items in Northwest Biotherapeutics, Inc.'s official results (Form 8-K, filed July 3, 2024); lowest support 87% of votes cast (Advisory Vote on 2023 Executive Compensation. The common and…). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the names NORTHWEST BIOTHERAPEUTICS, INC.; NORTHWEST BIOTHERAPEUTICS INC., as its holders filed it.

Explore Northwest Biotherapeutics, Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.